BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 29493463)

  • 1. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
    Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
    Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
    Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, antioxidants and neurodegenerative diseases.
    Casetta I; Govoni V; Granieri E
    Curr Pharm Des; 2005; 11(16):2033-52. PubMed ID: 15974957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components.
    Samanta S; Chakraborty S; Bagchi D
    J Am Nutr Assoc; 2024 Jan; 43(1):20-32. PubMed ID: 37186678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and neurodegenerative disorders.
    Sun AY; Chen YM
    J Biomed Sci; 1998; 5(6):401-14. PubMed ID: 9845843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants.
    Cui K; Luo X; Xu K; Ven Murthy MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):771-99. PubMed ID: 15363603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases.
    Teleanu DM; Niculescu AG; Lungu II; Radu CI; Vladâcenco O; Roza E; Costăchescu B; Grumezescu AM; Teleanu RI
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
    Halliwell B
    Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Oxidative Stress and Antioxidant Defense Biomarkers in Neurodegenerative Diseases.
    Saleem U; Sabir S; Niazi SG; Naeem M; Ahmad B
    Crit Rev Eukaryot Gene Expr; 2020; 30(4):311-322. PubMed ID: 32894661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of Potassium Channels in Neurodegenerative Diseases: A Mini-Review.
    Yang J; Yan X
    CNS Neurol Disord Drug Targets; 2018; 17(4):267-271. PubMed ID: 29422009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
    Sivandzade F; Prasad S; Bhalerao A; Cucullo L
    Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics.
    Pong K
    Expert Opin Biol Ther; 2003 Feb; 3(1):127-39. PubMed ID: 12718737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
    van Muiswinkel FL; Kuiperij HB
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.
    Szeto HH
    AAPS J; 2006 Aug; 8(3):E521-31. PubMed ID: 17025271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.